Results 251 to 260 of about 914,661 (291)
Some of the next articles are maybe not open access.
The Cancer Journal, 2007
Metastatic renal cell cancer has traditionally been treated with interferon and interleukin-2. An improved understanding of the biology of renal cancer has engendered novel targeted therapeutic agents that have altered the natural history of this disease.
Thomas E, Hutson, Robert A, Figlin
openaire +2 more sources
Metastatic renal cell cancer has traditionally been treated with interferon and interleukin-2. An improved understanding of the biology of renal cancer has engendered novel targeted therapeutic agents that have altered the natural history of this disease.
Thomas E, Hutson, Robert A, Figlin
openaire +2 more sources
Surgery (Oxford), 2002
This study was carried out 1) to analyze the growth and clinical manifestations of renal adenocarcinoma; 2) to determine the presence of tumor, its malignant nature, size, local extent or distant spread and route of dissemination according to the imaging methods utilized, and 3) to determine the accuracy of the different imaging procedures, such as IVP,
F J, Fernández Mena, C, Moreno Torres
openaire +3 more sources
This study was carried out 1) to analyze the growth and clinical manifestations of renal adenocarcinoma; 2) to determine the presence of tumor, its malignant nature, size, local extent or distant spread and route of dissemination according to the imaging methods utilized, and 3) to determine the accuracy of the different imaging procedures, such as IVP,
F J, Fernández Mena, C, Moreno Torres
openaire +3 more sources
Surgery (Oxford), 2006
AbstractMalignant tumors of the kidney account for about 2% of all new cancer cases in the United States and worldwide, with 38,890 cases and 12,840 deaths estimated for 2006 in the United States. This chapter reviews the epidemiology of renal cancer. Demographic patterns and risk factors are discussed.
Beverley A Wilkinson, David J Smith
openaire +2 more sources
AbstractMalignant tumors of the kidney account for about 2% of all new cancer cases in the United States and worldwide, with 38,890 cases and 12,840 deaths estimated for 2006 in the United States. This chapter reviews the epidemiology of renal cancer. Demographic patterns and risk factors are discussed.
Beverley A Wilkinson, David J Smith
openaire +2 more sources
2017
Renal cancers in adults are classified into two major groups according to the anatomic subsite of origin. The predominant group, originating from the renal parenchyma, is mostly renal cell carcinoma, which, in turn, is further classified into morphologically, clinically, and genetically distinct subtypes.
Wong-Ho Chow +2 more
openaire +2 more sources
Renal cancers in adults are classified into two major groups according to the anatomic subsite of origin. The predominant group, originating from the renal parenchyma, is mostly renal cell carcinoma, which, in turn, is further classified into morphologically, clinically, and genetically distinct subtypes.
Wong-Ho Chow +2 more
openaire +2 more sources
Hematology/Oncology Clinics of North America, 2023
Bradley A, McGregor, Toni K, Choueiri
openaire +2 more sources
Bradley A, McGregor, Toni K, Choueiri
openaire +2 more sources